ERBB2 and breast cancer: The expression of miR-371b-5p in the adjacent normal tissues was compared with that in tumors in clinical tissue specimens (non-TNBC [luminal and HER2 subtype] vs. TNBC) and observed to be significantly downregulated in TNBC than in other breast cancer subtypes (Fig. 1B).